These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7203579)

  • 21. The production and control of anti--venous sera.
    Bolaños R; Cerdas L
    Dev Biol Stand; 1978; 41():109-16. PubMed ID: 89053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological studies on erabutoxin b, a sea snake toxin. Attempts to locate the amino acid residues determining antigenicity.
    Abe T; Tamiya N
    Toxicon; 1979; 17(6):571-82. PubMed ID: 93322
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the method of determining the effect of antimyonecrotic factor antibody in Habu-antivenin [proceedings].
    Chinzei H
    Jpn J Med Sci Biol; 1978 Apr; 31(2):204-5. PubMed ID: 682381
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of low-dose snake antivenom in severe neurotoxic snake envenoming.
    Singh A; Agarwal R
    Am J Emerg Med; 2008 Nov; 26(9):1058-9. PubMed ID: 19091272
    [No Abstract]   [Full Text] [Related]  

  • 25. Snake bites in India and its management.
    Madhusudana SN; Aggarwal P
    J Indian Med Assoc; 1990 Aug; 88(8):235-6. PubMed ID: 2262710
    [No Abstract]   [Full Text] [Related]  

  • 26. Decrease in the lethal effect of snake venom by serum of the opossum, Didelphis marsupialis.
    Werner RM; Faith RE
    Lab Anim Sci; 1978 Dec; 28(6):710-3. PubMed ID: 750730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological studies on an Egyptian bivalent Naja antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1974 May; 12(3):321-3. PubMed ID: 4458113
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids.
    Ramos-Cerrillo B; de Roodt AR; Chippaux JP; Olguín L; Casasola A; Guzmán G; Paniagua-Solís J; Alagón A; Stock RP
    Toxicon; 2008 Dec; 52(8):881-8. PubMed ID: 18926842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
    Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
    Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extremely low nerve growth facior (NGF) activity of sea snake (Hydrophiidae) venoms.
    Mariam K; Tu AT
    J Nat Toxins; 2002 Dec; 11(4):393-8. PubMed ID: 12503884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Haffkine Institute polyvalent antivenin against Indian snake venoms.
    Kankonkar RC; Rao SS; Vad NE; Sant MV
    Indian J Med Res; 1972 Apr; 60(4):512-6. PubMed ID: 4633900
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot experiment for production of Malayan krait antivenom: immunization of rabbits with Bungarus candidus venom.
    Chanhome L; Puempunpanich S; Omori-Satoh T; Chaiyabutr N; Sitprija V
    J Nat Toxins; 2002 Dec; 11(4):353-6. PubMed ID: 12503879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J; O'Leary MA; Isbister GK
    Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venomous snakebites. Current concepts in diagnosis, treatment, and management.
    Gold BS; Barish RA
    Emerg Med Clin North Am; 1992 May; 10(2):249-67. PubMed ID: 1559468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The antigenicity of toxic proteins from the venoms of Elapidae and Hydrophiidae].
    Boquet P; Dumarey C; Joseph D
    C R Acad Hebd Seances Acad Sci D; 1977 Jun; 284(23):2439-42. PubMed ID: 409524
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the fractions of the venom of the sea snake Enhydrina schistosa.
    CAREY JE; WRIGHT EA
    Aust J Exp Biol Med Sci; 1962 Oct; 40():427-35. PubMed ID: 14018633
    [No Abstract]   [Full Text] [Related]  

  • 38. The site of action of the venom of the sea snake Enhydrina schistosa.
    CAREY JE; WRITHT EA
    Trans R Soc Trop Med Hyg; 1961 Mar; 55():153-60. PubMed ID: 13690775
    [No Abstract]   [Full Text] [Related]  

  • 39. Snake bite: coral snakes.
    Peterson ME
    Clin Tech Small Anim Pract; 2006 Nov; 21(4):183-6. PubMed ID: 17265902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of the neurotoxic component of the venom of the sea snake, Enhydrina schistosa.
    CAREY JE; WRIGHT EA
    Nature; 1960 Jan; 185():103-4. PubMed ID: 13807688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.